Home / World News / AstraZeneca betters estimates amid strong sales, Covid-19 vaccine hopes

AstraZeneca betters estimates amid strong sales, Covid-19 vaccine hopes

The company reiterated that it was on track with late-stage trials for its coronavirus vaccine, which could be rolled out by the year-end

Initiate suitable prosecution steps against AstraZeneca management, pleads FMRI

Premium

AstraZeneca's Covid-19 shot is widely considered the leading candidate

2 min read Last Updated : Jul 30 2020 | 3:20 PM IST

Britain's AstraZeneca bettered second-quarter sales and profit estimates on Thursday, thanks to strong sales during the lockdowns from the drugmaker's diverse product line-up, which now includes a front-running coronavirus vaccine candidate.

Optimism over its Covid-19 vaccine has fuelled what was already a strong year for the company as it also stuck by its 2020 outlook. AstraZeneca has gained from changes wrought by Chief Executive Pascal Soriot's focus on products and bets on newer medicines.

The company reiterated that it was on track with late-stage trials for its coronavirus vaccine, which could be rolled out by the year-end.

Shares of London's most valuable listed

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in